LGND logo

LGND Total expenses

Annual total expenses:

$171.16M+$93.67M(+120.87%)
December 31, 2024

Summary

  • As of today (September 14, 2025), LGND annual total expenses is $171.16 million, with the most recent change of +$93.67 million (+120.87%) on December 31, 2024.
  • During the last 3 years, LGND annual total expenses has risen by +$5.97 million (+3.62%).
  • LGND annual total expenses is now -38.17% below its all-time high of $276.82 million, reached on December 31, 2006.

Performance

LGND Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

Quarterly total expenses:

$42.78M-$45.00M(-51.27%)
June 30, 2025

Summary

  • As of today (September 14, 2025), LGND quarterly total expenses is $42.78 million, with the most recent change of -$45.00 million (-51.27%) on June 30, 2025.
  • Over the past year, LGND quarterly total expenses has dropped by -$50.66 million (-54.22%).
  • LGND quarterly total expenses is now -77.86% below its all-time high of $193.19 million, reached on March 31, 2006.

Performance

LGND Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLGNDincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

LGND Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+120.9%-54.2%
3 y3 years+3.6%+14.0%
5 y5 years+133.6%+121.3%

LGND Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-15.0%+120.9%-54.2%+177.6%
5 y5-year-15.0%+133.6%-54.2%+177.6%
alltimeall time-38.2%+133.6%-77.9%+106.9%

LGND Total expenses History

DateAnnualQuarterly
Jun 2025
-
$42.78M(-51.3%)
Mar 2025
-
$87.78M(+18.8%)
Dec 2024
$171.16M(+120.9%)
$73.90M(+25.3%)
Sep 2024
-
$58.98M(-36.9%)
Jun 2024
-
$93.44M(-269.4%)
Mar 2024
-
-$55.16M(-656.5%)
Dec 2023
$77.50M(-61.5%)
$9.91M(-77.0%)
Sep 2023
-
$43.14M(+79.2%)
Jun 2023
-
$24.08M(+6496.2%)
Mar 2023
-
$365.00K(-99.4%)
Dec 2022
$201.46M(+22.0%)
$64.92M(+30.9%)
Sep 2022
-
$49.58M(+32.1%)
Jun 2022
-
$37.53M(-24.1%)
Mar 2022
-
$49.45M(-17.0%)
Dec 2021
$165.19M(-12.8%)
$59.60M(+16.6%)
Sep 2021
-
$51.11M(-5.3%)
Jun 2021
-
$53.95M(+45.6%)
Mar 2021
-
$37.04M(-42.3%)
Dec 2020
$189.40M(-137.2%)
$64.23M(+32.3%)
Sep 2020
-
$48.55M(+151.1%)
Jun 2020
-
$19.33M(-66.3%)
Mar 2020
-
$57.29M(+66.7%)
Dec 2019
-$509.02M(-570.7%)
$34.37M(-14.2%)
Sep 2019
-
$40.06M(+1.7%)
Jun 2019
-
$39.41M(-106.3%)
Mar 2019
-
-$622.85M(-710.2%)
Dec 2018
$108.13M(-15.9%)
$102.07M(-570.4%)
Sep 2018
-
-$21.70M(-228.5%)
Jun 2018
-
$16.88M(+55.2%)
Mar 2018
-
$10.88M(-81.1%)
Dec 2017
$128.55M(+15.5%)
$57.47M(+130.4%)
Sep 2017
-
$24.95M(+13.7%)
Jun 2017
-
$21.94M(-9.3%)
Mar 2017
-
$24.19M(-41.5%)
Dec 2016
$111.34M(-170.5%)
$41.31M(+100.9%)
Sep 2016
-
$20.57M(-19.9%)
Jun 2016
-
$25.69M(+8.1%)
Mar 2016
-
$23.77M(+60.1%)
Dec 2015
-$157.91M(-400.7%)
$14.85M(-108.2%)
Sep 2015
-
-$181.46M(+3426.3%)
Jun 2015
-
-$5.15M(-137.2%)
Mar 2015
-
$13.85M(-13.1%)
Dec 2014
$52.51M(+30.8%)
$15.94M(+16.4%)
Sep 2014
-
$13.69M(+51.9%)
Jun 2014
-
$9.02M(-35.0%)
Mar 2014
-
$13.86M(+7.7%)
Dec 2013
$40.14M(+17.8%)
$12.87M(+16.5%)
Sep 2013
-
$11.04M(+87.6%)
Jun 2013
-
$5.89M(-43.1%)
Mar 2013
-
$10.35M(-6.4%)
Dec 2012
$34.06M(+67.6%)
$11.05M(+68.2%)
Sep 2012
-
$6.57M(-33.0%)
Jun 2012
-
$9.81M(+60.2%)
Mar 2012
-
$6.12M(-22.4%)
Dec 2011
$20.32M(-44.0%)
$7.89M(-20.4%)
Sep 2011
-
$9.92M(+18.4%)
Jun 2011
-
$8.38M(-236.6%)
Mar 2011
-
-$6.13M(+989.2%)
Dec 2010
$36.32M(-23.2%)
-$563.00K(-102.9%)
Sep 2010
-
$19.64M(+220.9%)
Jun 2010
-
$6.12M(-31.6%)
Mar 2010
-
$8.95M(-30.9%)
Dec 2009
$47.28M
$12.94M(+89.1%)
DateAnnualQuarterly
Sep 2009
-
$6.85M(-43.3%)
Jun 2009
-
$12.07M(-28.8%)
Mar 2009
-
$16.95M(-80.3%)
Dec 2008
$124.78M(+161.8%)
$86.12M(+499.2%)
Sep 2008
-
$14.37M(+48.3%)
Jun 2008
-
$9.69M(-33.6%)
Mar 2008
-
$14.59M(+31.5%)
Dec 2007
$47.65M(-82.8%)
$11.09M(+7.3%)
Sep 2007
-
$10.34M(+13.7%)
Jun 2007
-
$9.10M(-46.9%)
Mar 2007
-
$17.12M(-363.4%)
Dec 2006
$276.82M(+30.0%)
-$6.50M(-112.3%)
Sep 2006
-
$52.85M(-17.9%)
Jun 2006
-
$64.41M(-66.7%)
Mar 2006
-
$193.19M(+273.0%)
Dec 2005
$213.01M(+2.1%)
$51.79M(+1.5%)
Sep 2005
-
$51.04M(-6.7%)
Jun 2005
-
$54.72M(-1.3%)
Mar 2005
-
$55.46M(+11.5%)
Dec 2004
$208.65M(+18.2%)
$49.72M(-10.0%)
Sep 2004
-
$55.27M(+1.7%)
Jun 2004
-
$54.34M(+10.2%)
Mar 2004
-
$49.33M(-0.7%)
Dec 2003
$176.60M(+36.6%)
$49.66M(+17.2%)
Sep 2003
-
$42.37M(+3.0%)
Jun 2003
-
$41.12M(-5.3%)
Mar 2003
-
$43.44M(+27.6%)
Dec 2002
$129.24M(+8.3%)
$34.05M(+5.4%)
Sep 2002
-
$32.31M(+2.9%)
Jun 2002
-
$31.41M(-0.2%)
Mar 2002
-
$31.46M(-11.9%)
Dec 2001
$119.34M(+11.1%)
$35.70M(+32.6%)
Sep 2001
-
$26.92M(-4.2%)
Jun 2001
-
$28.10M(-1.8%)
Mar 2001
-
$28.62M(+7.8%)
Dec 2000
$107.39M(-7.1%)
$26.54M(-1.7%)
Sep 2000
-
$27.00M(-0.9%)
Jun 2000
-
$27.23M(+2.3%)
Mar 2000
-
$26.62M(-24.6%)
Dec 1999
$115.61M(-14.7%)
$35.29M(+25.7%)
Sep 1999
-
$28.07M(+2.4%)
Jun 1999
-
$27.41M(+10.4%)
Mar 1999
-
$24.84M(-44.7%)
Dec 1998
$135.56M(-10.7%)
$44.93M(-10.5%)
Sep 1998
-
$50.22M(+130.4%)
Jun 1998
-
$21.80M(+17.2%)
Mar 1998
-
$18.61M(-21.5%)
Dec 1997
$151.85M(+104.8%)
$23.70M(+15.6%)
Sep 1997
-
$20.50M(+6.2%)
Jun 1997
-
$19.30M(+2.1%)
Mar 1997
-
$18.90M(-6.4%)
Dec 1996
$74.16M(-16.4%)
$20.20M(+18.1%)
Sep 1996
-
$17.10M(-1.7%)
Jun 1996
-
$17.40M(+16.8%)
Mar 1996
-
$14.90M(-2.6%)
Dec 1995
$88.69M(+119.6%)
$15.30M(+7.0%)
Sep 1995
-
$14.30M(+64.4%)
Mar 1995
-
$8.70M(-9.4%)
Dec 1994
$40.39M(+13.1%)
$9.60M(+12.9%)
Sep 1994
-
$8.50M(+3.7%)
Jun 1994
-
$8.20M(+3.8%)
Mar 1994
-
$7.90M
Dec 1993
$35.72M(+79.6%)
-
Dec 1992
$19.89M
-

FAQ

  • What is Ligand Pharmaceuticals Incorporated annual total expenses?
  • What is the all time high annual total expenses for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated annual total expenses year-on-year change?
  • What is Ligand Pharmaceuticals Incorporated quarterly total expenses?
  • What is the all time high quarterly total expenses for Ligand Pharmaceuticals Incorporated?
  • What is Ligand Pharmaceuticals Incorporated quarterly total expenses year-on-year change?

What is Ligand Pharmaceuticals Incorporated annual total expenses?

The current annual total expenses of LGND is $171.16M

What is the all time high annual total expenses for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high annual total expenses is $276.82M

What is Ligand Pharmaceuticals Incorporated annual total expenses year-on-year change?

Over the past year, LGND annual total expenses has changed by +$93.67M (+120.87%)

What is Ligand Pharmaceuticals Incorporated quarterly total expenses?

The current quarterly total expenses of LGND is $42.78M

What is the all time high quarterly total expenses for Ligand Pharmaceuticals Incorporated?

Ligand Pharmaceuticals Incorporated all-time high quarterly total expenses is $193.19M

What is Ligand Pharmaceuticals Incorporated quarterly total expenses year-on-year change?

Over the past year, LGND quarterly total expenses has changed by -$50.66M (-54.22%)
On this page